Malcolm McDonald
Cardiovascular Disease · Weston, FLNPI 1215496534
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Medtronic at 35.4% of the total. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.
Across 150 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Novartis$473
- Boston Scientific$383
- Abbott$249
- Impulse Dynamics (USA) Inc.$178
- Heartflow, Inc.$153
- plus $505 from 14 others
What the payments were for
- Food & beverage$3,005100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 78 | $1,064 |
| Novartis | 39 | $473 |
| Boston Scientific | 7 | $383 |
| Abbott | 5 | $249 |
| Impulse Dynamics (USA) Inc. | 1 | $178 |
| Heartflow, Inc. | 2 | $153 |
| Amgen | 3 | $68 |
| Novo Nordisk | 3 | $56 |
| Kestra Medical Technology Services, Inc. | 1 | $54 |
| Abiomed | 1 | $43 |
| Biotronik Inc. | 1 | $42 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $31 |
| Boehringer Ingelheim | 1 | $31 |
| Philips North America LLC | 1 | $30 |
| Vital Connect, Inc | 1 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
| Johnson & Johnson | 1 | $20 |
| Terumo Medical Corporation | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$356
- AVEIR$177
- GENERAL - THERAPIES$131
- FFRct$123
- RESONATE EL ICD VR$101
How this compares
$3,005 in reported general payments places this provider in the 50th percentile of 1,740 cardiovascular disease providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $15,053 |
| Ranolazine ErRanolazine | 12 | $636 |
| ClopidogrelClopidogrel Bisulfate | 34 | $412 |
| Metoprolol Succinate | 19 | $264 |
| Spironolactone | 15 | $132 |
| Rosuvastatin Calcium | 11 | $118 |
| Atorvastatin Calcium | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Weston
- David WolinskyWeston$390K
- Kevin MakatiLutz$1.6M
- Hiram BezerraTampa$698K
- William OneillNaples$637K
- Theodore FeldmanMiami$637K
- John Gerald CantoLakeland$588K
- Alan MillerJacksonville$547K
- Seth BaumBoca Raton$517K
- Elliott EliasMiami$497K
- Vijay HaryaniVero Beach$413K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.